Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 staff in Maryland.

Earlier this month, Merck and Daiichi Sankyo announced that ifinatamab deruxtecan was granted Breakthrough Therapy Designation by the U.S. FDA for treating adult patients with extensive-stage small ...

TOKYO: Japan’s Nikkei share average fell for a third session on Thursday as investors sold stocks to book profits from a ...

The two trading partners documented provisions of a deal that would set a 15% tariff on many EU imports, including cars, auto ...

The Delhi High Court recently clarified that it does not have the power to directly attach immovable properties situated outside its territorial jurisdiction even for enforcement of foreign arbitral ...

Asia-Pacific markets mostly rose, with Australian stocks among the top gainers, breaking ranks with key Wall Street peers that saw declines led by tech stocks. In Japan, the Nikkei lost 278.38 points, ...

Daiichi Sankyo Co. shares dropped the most in three months following a series of discounted block trades in the Japanese pharmaceutical company.

Japan's Nikkei share average fell for a third session on Thursday as investors sold stocks to book profits from a recent rally, with technology stocks tracking U.S. peers lower.

Japan’s Nikkei share average fell on Thursday as investors sold stocks to book profits from a recent rally, with technology ...

Investors in the region are awaiting India's HSBC Composite flash purchasing managers' index reading for August expected ...

A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...